{"id":52265,"date":"2025-12-30T20:39:47","date_gmt":"2025-12-30T12:39:47","guid":{"rendered":"https:\/\/flcube.com\/?p=52265"},"modified":"2025-12-30T20:39:50","modified_gmt":"2025-12-30T12:39:50","slug":"edge-medical-raises-hk1-2-billion-in-hong-kong-ipo-to-fund-surgical-robot-pipeline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=52265","title":{"rendered":"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline"},"content":{"rendered":"\n<p><strong>Shenzhen Edge Medical Co., Ltd.<\/strong> (HKG: 2675) has officially listed on the <strong>Main Board of the Hong Kong Stock Exchange<\/strong>, offering <strong>27,722,200 shares<\/strong> at <strong>HK$43.24<\/strong> per share to raise nearly <strong>HK$1.2\u202fbillion<\/strong> (US$154\u202fmillion). The company, founded in 2017, is positioned as a leading domestic surgical robotics developer with a diversified portfolio spanning laparoscopic and natural orifice systems.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ipo-terms\">IPO Terms<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Issuer<\/strong><\/td><td>Shenzhen Edge Medical Co., Ltd. (2675.HK)<\/td><\/tr><tr><td><strong>Listing Venue<\/strong><\/td><td>Hong Kong Stock Exchange Main Board<\/td><\/tr><tr><td><strong>Offering Size<\/strong><\/td><td>27,722,200 shares (global offering)<\/td><\/tr><tr><td><strong>Offer Price<\/strong><\/td><td>HK$43.24 per share<\/td><\/tr><tr><td><strong>Total Proceeds<\/strong><\/td><td>HK$1.198\u202fbillion (US$154\u202fmillion)<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>30\u202fDec\u202f2025<\/td><\/tr><tr><td><strong>Founding Year<\/strong><\/td><td>2017<\/td><\/tr><tr><td><strong>Business Focus<\/strong><\/td><td>Surgical robotics design, development, manufacturing<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-portfolio-amp-pipeline\">Product Portfolio &amp; Pipeline<\/h2>\n\n\n\n<p>Edge Medical has developed <strong>three core product categories<\/strong> targeting different minimally invasive surgery paradigms:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Product Category<\/th><th>Description<\/th><th>Development Stage<\/th><th>Target Indications<\/th><\/tr><\/thead><tbody><tr><td><strong>Multi\u2011port Laparoscopic Robots<\/strong><\/td><td>Multi\u2011arm robotic systems for complex abdominal\/pelvic procedures<\/td><td>Commercial\/late\u2011stage clinical<\/td><td>General surgery, gynecology, urology<\/td><\/tr><tr><td><strong>Single\u2011port Laparoscopic Robots<\/strong><\/td><td>Compact single\u2011incision platforms for reduced surgical trauma<\/td><td>Clinical trials<\/td><td>Cholecystectomy, nephrectomy, colorectal<\/td><\/tr><tr><td><strong>Natural Orifice Transluminal Robots<\/strong><\/td><td>Scar\u2011less robotic systems accessing via mouth, anus, or vagina<\/td><td>Early\u2011stage R&amp;D<\/td><td>NOTES procedures, gastrectomy, colorectal<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The portfolio addresses the <strong>full spectrum of surgical invasiveness<\/strong>, from conventional multi\u2011port to next\u2011generation scar\u2011less surgery.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-opportunity\">Market Context &amp; Opportunity<\/h2>\n\n\n\n<p><strong>China Surgical Robotics Market<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Size<\/strong>: <strong>\u00a518\u202fbillion<\/strong> (\u2248\u202fUS$2.5\u202fbillion) in 2025, projected to reach <strong>\u00a565\u202fbillion<\/strong> (US$9.1\u202fbillion) by 2030, growing at a <strong>29% CAGR<\/strong><\/li>\n\n\n\n<li><strong>Penetration Rate<\/strong>: Only <strong>3\u20115%<\/strong> of eligible procedures currently use robotic assistance vs. <strong>15\u201120%<\/strong> in the US<\/li>\n\n\n\n<li><strong>Policy Tailwind<\/strong>: NMPA\u2019s <strong>&#8220;Innovative Medical Device&#8221;<\/strong> pathway and <strong>DRG reimbursement<\/strong> reforms favor domestic robotics<\/li>\n<\/ul>\n\n\n\n<p><strong>Growth Drivers<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Aging population and rising cancer incidence<\/li>\n\n\n\n<li>Surgeon shortage driving demand for automation<\/li>\n\n\n\n<li><strong>Made\u2011in\u2011China 2025<\/strong> initiative supporting high\u2011end medical device localization<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-competitive-landscape\">Competitive Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Company<\/th><th>Product<\/th><th>Origin<\/th><th>China Status<\/th><th>Market Share (2025)<\/th><\/tr><\/thead><tbody><tr><td><strong>Intuitive Surgical<\/strong><\/td><td>da Vinci Xi\/X<\/td><td>US<\/td><td>Approved (imported)<\/td><td>~65%<\/td><\/tr><tr><td><strong>MicroPort<\/strong><\/td><td>Toumai<\/td><td>China<\/td><td>Approved (2022)<\/td><td>~18%<\/td><\/tr><tr><td><strong>Medtronic<\/strong><\/td><td>Hugo<\/td><td>US<\/td><td>Clinical trials<\/td><td>~5%<\/td><\/tr><tr><td><strong>Edge Medical<\/strong><\/td><td><strong>Multi\u2011port\/Single\u2011port<\/strong><\/td><td>China<\/td><td><strong>Pre\u2011market approval pending<\/strong><\/td><td><strong>~0% (pre\u2011commercial)<\/strong><\/td><\/tr><tr><td><strong>Others<\/strong><\/td><td>Stryker, CMR Surgical<\/td><td>EU\/US<\/td><td>Limited presence<\/td><td>~12%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Strategic Position<\/strong>: Edge Medical aims to <strong>undercut da Vinci on price<\/strong> (projected 30\u201140% discount) while offering <strong>single\u2011port and NOTES capabilities<\/strong> that Intuitive lacks in China.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-use-of-proceeds\">Use of Proceeds<\/h2>\n\n\n\n<p>The HK$1.2\u202fbillion net proceeds are allocated as follows:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Use Category<\/th><th>Amount (HK$ million)<\/th><th>% of Proceeds<\/th><th>Timeline<\/th><\/tr><\/thead><tbody><tr><td><strong>R&amp;D &amp; Clinical Trials<\/strong><\/td><td>450<\/td><td>37.6%<\/td><td>2026\u20112028<\/td><\/tr><tr><td><strong>Commercialization &amp; Sales Network<\/strong><\/td><td>320<\/td><td>26.7%<\/td><td>2026\u20112027<\/td><\/tr><tr><td><strong>Manufacturing Capacity Expansion<\/strong><\/td><td>250<\/td><td>20.9%<\/td><td>2026\u20112029<\/td><\/tr><tr><td><strong>Working Capital &amp; General Corporate<\/strong><\/td><td>178<\/td><td>14.8%<\/td><td>Ongoing<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Manufacturing<\/strong>: Edge Medical operates a <strong>12,000\u202fm\u00b2 GMP facility<\/strong> in Shenzhen with capacity for <strong>200 units\/year<\/strong>, scalable to <strong>500 units\/year<\/strong> by 2027.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-projections\">Financial Projections<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>2026E<\/th><th>2027E<\/th><th>2028E<\/th><\/tr><\/thead><tbody><tr><td><strong>Unit Sales (robots)<\/strong><\/td><td>15\u201120<\/td><td>45\u201160<\/td><td>90\u2011120<\/td><\/tr><tr><td><strong>Average Selling Price (HK$)<\/strong><\/td><td>2.5\u202fmillion<\/td><td>2.3\u202fmillion<\/td><td>2.1\u202fmillion<\/td><\/tr><tr><td><strong>Revenue (HK$ million)<\/strong><\/td><td>38\u201150<\/td><td>104\u2011138<\/td><td>189\u2011252<\/td><\/tr><tr><td><strong>Gross Margin<\/strong><\/td><td>55\u201160%<\/td><td>60\u201165%<\/td><td>65\u201170%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>Negative<\/td><td>Break\u2011even<\/td><td>15\u201120%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Profitability Path<\/strong>: Management targets <strong>break\u2011even by 2028<\/strong> based on <strong>150\u2011unit cumulative sales<\/strong>.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding Edge Medical\u2019s market penetration, revenue forecasts, and profitability timeline. Actual results may differ materially due to competitive responses, regulatory approval delays, and market adoption rates for robotic surgery in China.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shenzhen Edge Medical Co., Ltd. (HKG: 2675) has officially listed on the Main Board of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":52269,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4522,4523,72],"class_list":["post-52265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-edge-medical","tag-hkg-2675","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shenzhen Edge Medical Co., Ltd. (HKG: 2675) has officially listed on the Main Board of the Hong Kong Stock Exchange, offering 27,722,200 shares at HK$43.24 per share to raise nearly HK$1.2\u202fbillion (US$154\u202fmillion). The company, founded in 2017, is positioned as a leading domestic surgical robotics developer with a diversified portfolio spanning laparoscopic and natural orifice systems.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=52265\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline\" \/>\n<meta property=\"og:description\" content=\"Shenzhen Edge Medical Co., Ltd. (HKG: 2675) has officially listed on the Main Board of the Hong Kong Stock Exchange, offering 27,722,200 shares at HK$43.24 per share to raise nearly HK$1.2\u202fbillion (US$154\u202fmillion). The company, founded in 2017, is positioned as a leading domestic surgical robotics developer with a diversified portfolio spanning laparoscopic and natural orifice systems.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=52265\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-30T12:39:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-30T12:39:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3001-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"596\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline\",\"datePublished\":\"2025-12-30T12:39:47+00:00\",\"dateModified\":\"2025-12-30T12:39:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265\"},\"wordCount\":514,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3001-1.webp\",\"keywords\":[\"Edge Medical\",\"HKG: 2675\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52265#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=52265\",\"name\":\"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3001-1.webp\",\"datePublished\":\"2025-12-30T12:39:47+00:00\",\"dateModified\":\"2025-12-30T12:39:50+00:00\",\"description\":\"Shenzhen Edge Medical Co., Ltd. (HKG: 2675) has officially listed on the Main Board of the Hong Kong Stock Exchange, offering 27,722,200 shares at HK$43.24 per share to raise nearly HK$1.2\u202fbillion (US$154\u202fmillion). The company, founded in 2017, is positioned as a leading domestic surgical robotics developer with a diversified portfolio spanning laparoscopic and natural orifice systems.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52265\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3001-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3001-1.webp\",\"width\":1080,\"height\":596,\"caption\":\"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO as Surgical Robotics Leader\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52265#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline - Insight, China&#039;s Pharmaceutical Industry","description":"Shenzhen Edge Medical Co., Ltd. (HKG: 2675) has officially listed on the Main Board of the Hong Kong Stock Exchange, offering 27,722,200 shares at HK$43.24 per share to raise nearly HK$1.2\u202fbillion (US$154\u202fmillion). The company, founded in 2017, is positioned as a leading domestic surgical robotics developer with a diversified portfolio spanning laparoscopic and natural orifice systems.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=52265","og_locale":"en_US","og_type":"article","og_title":"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline","og_description":"Shenzhen Edge Medical Co., Ltd. (HKG: 2675) has officially listed on the Main Board of the Hong Kong Stock Exchange, offering 27,722,200 shares at HK$43.24 per share to raise nearly HK$1.2\u202fbillion (US$154\u202fmillion). The company, founded in 2017, is positioned as a leading domestic surgical robotics developer with a diversified portfolio spanning laparoscopic and natural orifice systems.","og_url":"https:\/\/flcube.com\/?p=52265","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-30T12:39:47+00:00","article_modified_time":"2025-12-30T12:39:50+00:00","og_image":[{"width":1080,"height":596,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3001-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=52265#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=52265"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline","datePublished":"2025-12-30T12:39:47+00:00","dateModified":"2025-12-30T12:39:50+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=52265"},"wordCount":514,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=52265#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3001-1.webp","keywords":["Edge Medical","HKG: 2675","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=52265#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=52265","url":"https:\/\/flcube.com\/?p=52265","name":"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=52265#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=52265#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3001-1.webp","datePublished":"2025-12-30T12:39:47+00:00","dateModified":"2025-12-30T12:39:50+00:00","description":"Shenzhen Edge Medical Co., Ltd. (HKG: 2675) has officially listed on the Main Board of the Hong Kong Stock Exchange, offering 27,722,200 shares at HK$43.24 per share to raise nearly HK$1.2\u202fbillion (US$154\u202fmillion). The company, founded in 2017, is positioned as a leading domestic surgical robotics developer with a diversified portfolio spanning laparoscopic and natural orifice systems.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=52265#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=52265"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=52265#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3001-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3001-1.webp","width":1080,"height":596,"caption":"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO as Surgical Robotics Leader"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=52265#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3001-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52265"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52265\/revisions"}],"predecessor-version":[{"id":52270,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52265\/revisions\/52270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/52269"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}